To cite this paper use one of the standards below:
Cardiovascular diseases are the most relevant death cause worldwide1. Although there are several cardiovascular drugs, new potent vasodilating agents are always pursuited2. We serendipitously found that LINS01005 is a potent vasodilator in rats’ aorta, and thus novel LINS01 compounds were examined. The rings [with (E+) and without (E-) endothelium] were extracted from Wistar rats (n=6/group) and placed in an isolated organ bath equipped with a tensiometer3. The rings were pre-contracted with norepinephrine and the vasodilating potency measured as –logEC50 (concentration to reduce 50% of the tension, pEC50). LINS01005 was the most potent [pEC50 7.1(E+) and 6.8(E-)] followed by the LINS01011 [pEC50 6.8(E+) and 5.5(E-)], being comparable to several known drugs. SAR analysis suggests that substitution in the aromatic ring is detrimental to the activity, and that N-phenylpiperazine is necessary to keep the efficacy. In summary, this work added information to better designing a new set of compounds.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper